Navigation Links
FlowCardia, Inc. Launches FlowMate(TM) Injector to Optimize Performance of CROSSER(R) CTO Recanalization Catheter
Date:10/6/2009

SUNNYVALE, Calif., Oct. 6 /PRNewswire/ -- FlowCardia, Inc., a worldwide leader in the development of endovascular devices for the treatment of chronic total occlusions (CTOs), has launched the FlowMate Injector, which dramatically simplifies central lumen crossing of CTOs using the CROSSER CTO Recanalization Catheter.

FlowMate provides unparalleled convenience by granting full control of the procedure to a physician via a single foot pedal, which initiates FlowMate's precise saline delivery as well as the Generator which activates the CROSSER Catheter. Fixed injector settings are integrated into the FlowMate adding even greater convenience and ease of use. A single IV pole houses both the FlowMate and Generator allowing for complete system integration.

"This is a significant improvement to the CROSSER CTO Recanalization System and it takes most of the learning curve out of the equation," said Dr. Cezar Staniloae of St. Vincent's Hospital in New York. "Set up is fast and using the new system affords me more time to focus on the patient and specifically, crossing the chronic occlusion with the CROSSER Catheter."

"We are excited to add this important product to our portfolio and to see the benefits to physicians and patients through enhanced CROSSER Catheter performance," said Chris Barys, Chief Operating Officer of FlowCardia. "FlowMate allows for complete CROSSER Catheter system integration and puts the power into the physician's hands, even when faced with the most difficult CTOs."

The CROSSER Catheter is a minimally-invasive endovascular device that utilizes high-frequency, mechanical vibration to facilitate passage through blockages in the peripheral and coronary arteries. It is designed as a frontline therapy to enable central lumen crossing of chronically occluded arteries thereby maximizing physicians' therapeutic options. Over 7,500 CROSSER Catheter procedures have been performed to date by physicians around the world.

About FlowCardia, Inc.

FlowCardia, Inc. is a privately held medical device company established in 2002 to design and manufacture a portfolio of endovascular CTO recanalization products. The CROSSER CTO Recanalization Catheter, steerable support catheters, and Porter guidewires comprise a family of tools which enable physicians to quickly cross chronic total occlusions allowing for subsequent balloon angioplasty, atherectomy, and/or stent placement. Additional information is available on the company's web site at: www.flowcardia.com.

    PR Contact Info:
    Mark Page
    Sr. Director, Marketing
    FlowCardia, Inc.
    408-617-0352 ext. 301

SOURCE FlowCardia, Inc.


'/>"/>
SOURCE FlowCardia, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FlowCardia, Inc. Appoints Chris Barys Senior VP, Sales
2. $16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer
3. Optical Express Launches Television Advertisement for the Cosmetic Clinic
4. Seidman Law Offices of Chicago Launches New Websites for FELA, Railroad Injury, and Civil Rights Claims
5. Mesoone.com Launches Official Portal With Access To Effective And Affordable Mesotherapy Products
6. The American Academy of Family Physicians Launches Consumer Alliance With First Partner: The Coca-Cola Company
7. SAGE launches Genes & Cancer
8. Typhoon Parma: World Vision Launches Relief Efforts in the Philippines, Pre-positions Supplies in Taiwan
9. Crohn's & Colitis Foundation Launches New Web Site to Commence Take Steps Walk Season: Walkers Can Take the Step that Counts Using New Interactive Features
10. As Environmental Regulations Gather on the Horizon, Crothall Services Group Launches Green Initiatives to Assist Hospitals
11. VisionSync Launches a Smart iPhone First Aid App, iMobile Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2017)... NC (PRWEB) , ... May 19, 2017 , ... ... the Charlotte health community, Queens University of Charlotte recently began recruitment efforts for ... program’s curriculum arms students with the skills, knowledge and expertise to approach and ...
(Date:5/19/2017)... ... May 19, 2017 , ... When Kyle Busch graduates from ... will already appear on two major research studies that could impact the health of ... Matt Daggett, KCU alumnus and an orthopedic surgeon, alongside an international team trying to ...
(Date:5/19/2017)... (PRWEB) , ... May 19, 2017 , ... The Hill ... to families and entrepreneurs throughout the California Central Valley, is announcing a joint charity ... raising community support for a local kid’s camp event. , The Boys and Girls ...
(Date:5/19/2017)... ... May 19, 2017 , ... The Arnold and Mabel ... , Victor Acosta, Ph.D. - University of New Mexico, Jeremy Baskin, Ph.D. - ... of Washington, Erik Grumstrup, Ph.D. - Montana Stata University, A. Fatih Sarioglu, Ph.D. ...
(Date:5/19/2017)... GA (PRWEB) , ... May 19, 2017 , ... As ... Miller knows the importance of prostate cancer screenings. Early detection of the disease, ... head of robotic surgery at Georgia Urology , stands alongside the Georgia Comprehensive ...
Breaking Medicine News(10 mins):
(Date:5/3/2017)... May 3, 2017  West Pharmaceutical Services, Inc. ... for injectable drug administration, announced today that ... Technical Services, and Diane Paskiet , Director, ... presentations focused on West,s expertise in the areas ... well as providing commentary on updated industry guidance. ...
(Date:5/2/2017)...  George Clinical, a leading full-service CRO in the ... Oncology, a Memphis -based leader ... that George Clinical has acquired Vector Oncology,s Pharma Services (CRO) ... purpose of strengthening the ability of George Clinical ... throughout the Asia-Pacific , the ...
(Date:5/2/2017)... PASO ROBLES, Calif. , May 2, 2017  Bayer ... have received grants from Healthy Hives 2020, a $1 million ... in the U.S. by the end of 2020. ... Dr. Olav Rueppell , University of North Carolina at ... currently available honey bees; Dr. Edmund ...
Breaking Medicine Technology: